Advances in Molecular and Clinical Subtyping of Breast Cancer and Their Implications for Therapy

被引：27
|
作者：
Cadoo, Karen A. [1 ]
Traina, Tiffany A. [2 ]
King, Tari A. [3 ]
机构：
[1] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10065 USA
[2] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med,Breast Canc Med Serv, New York, NY 10065 USA
[3] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Surg,Breast Serv, New York, NY 10065 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2013年 / 22卷 / 04期
关键词：
Breast cancer; Intrinsic subtypes; Endocrine therapy; HER2; positive; Triple negative; Resistance; RANDOMIZED PHASE-II; GENE-EXPRESSION; ENDOCRINE THERAPY; TRASTUZUMAB RESISTANCE; ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; TUMOR SUBTYPES; OPEN-LABEL; RECEPTOR; TAMOXIFEN;
D O I：
10.1016/j.soc.2013.06.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The identification of the intrinsic molecular subtypes of breast cancer has enhanced our understanding of tumor biology, informing therapeutic targets, and clinical trial design. This article reviews the intrinsic classification system and the clinically defined subtypes of breast cancer. We review the molecular drivers of each subtype and discuss implications for prognosis, clinical management, and future directions.
引用
收藏
页码：823 / +
页数：19
相关论文
共 50 条
  • [1] MOLECULAR SUBTYPING OF EARLY-STAGE BREAST CANCER: IMPLICATIONS FOR RADIATION THERAPY
    Haffty, Bruce G.
    Goyal, Sharad
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (05): : 1293 - 1295
  • [2] Clinical implications of molecular subtyping in bladder cancer
    Satyal, Uttam
    Sikder, Rahmat K.
    McConkey, David
    Plimack, Elizabeth R.
    Abbosh, Philip H.
    [J]. CURRENT OPINION IN UROLOGY, 2019, 29 (04) : 350 - 356
  • [3] Evolving molecular subtyping of breast cancer advances precision treatment
    Rui Shan
    LeiJie Dai
    ZhiMing Shao
    YiZhou Jiang
    [J]. Cancer Biology & Medicine., 2024, 21 (09) - 739
  • [4] Evolving molecular subtyping of breast cancer advances precision treatment
    Shan, Rui
    Dai, Lei-Jie
    Shao, Zhi-Ming
    Jiang, Yi-Zhou
    [J]. CANCER BIOLOGY & MEDICINE, 2024, 21 (09) : 731 - 739
  • [5] MammaPrint and BluePrint in early breast cancer: Clinical implications of prognostic stratification and molecular subtyping
    Yao, K.
    Turk, M.
    Kaul, K.
    Wesseling, J.
    Stork-Sloots, L.
    de Snoo, F.
    Cristofanilli, M.
    [J]. CANCER RESEARCH, 2013, 73
  • [6] MOLECULAR GENETICS OF BREAST AND OVARIAN CANCER: RECENT ADVANCES AND CLINICAL IMPLICATIONS
    Bogdanova, N.
    Doerk, T.
    [J]. BALKAN JOURNAL OF MEDICAL GENETICS, 2012, 15 : 75 - 80
  • [7] Subtyping of Triple-Negative Breast Cancer: Implications for Therapy
    Abramson, Vandana G.
    Lehmann, Brian D.
    Ballinger, Tarah J.
    Pietenpol, Jennifer A.
    [J]. CANCER, 2015, 121 (01) : 8 - 16
  • [8] Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
    Asleh, Karama
    Riaz, Nazia
    Nielsen, Torsten O.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [9] Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
    Karama Asleh
    Nazia Riaz
    Torsten O. Nielsen
    [J]. Journal of Experimental & Clinical Cancer Research, 41
  • [10] Molecular Mechanism and Clinical Implications of Endocrine Therapy Resistance in Breast Cancer
    Arpino, Grazia
    De Angelis, Carmine
    Giuliano, Mario
    Giordano, Antonio
    Falato, Claudette
    De Laurentiis, Michele
    De Placido, Sabino
    [J]. ONCOLOGY, 2009, 77 : 23 - 37
12345